ENTX.NASDAQEntera Bio LTD

SCHEDULE: Point72 Discloses 2.6% Stake in Entera Bio Ltd.

Sentiment:

Beneficial Ownership Report


Point72 Asset Management, along with Point72 Capital Advisors Inc. and Steven A. Cohen, reported a 2.6% beneficial ownership stake in Entera Bio Ltd. as of September 30, 2025.

Summary

  • Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen collectively reported beneficial ownership of 1,183,116 ordinary shares of Entera Bio Ltd.
  • This beneficial ownership represents 2.6% of the total class of Entera Bio Ltd.'s ordinary shares.
  • The ownership position is reported as of September 30, 2025, which is the date of the event requiring this filing.
  • The reporting persons hold shared voting power over 1,183,116 shares and shared dispositive power over 1,183,116 shares, with no sole voting or dispositive power.

Sentiment

Score: 5

Explanation: This is a neutral informational filing regarding beneficial ownership and does not contain performance or operational data to assess sentiment.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's operations or financial performance.

Industry Context

This filing reflects a passive investment by a prominent asset management firm, Point72, in Entera Bio Ltd. Such disclosures are routine for institutional investors and provide transparency on significant holdings in publicly traded companies.

Stakeholder Impact

  • Provides transparency to shareholders and the market regarding significant passive ownership by Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen in Entera Bio Ltd.

Key Dates

DateDescription
09/30/2025Date of the event which requires the filing of this statement, reflecting the beneficial ownership percentage.
11/14/2025Date the Schedule 13G Amendment No. 1 was signed and filed.

Keywords

Entera Bio Ltd., Point72 Asset Management, Steven A. Cohen, Beneficial Ownership, Schedule 13G, M40527109, Ordinary Shares, Investment Fund

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.